Impact of infusion timing (IT) on survival outcomes across gastrointestinal (GI) malignancies: A multicenter analysis of circadian rhythm (CR) effects on immune checkpoint inhibitor (ICI) activity.
Fares Jamal(WinnMed), Mohamad Bassam Sonbol(WinnMed), Robert R. McWilliams(Mayo Clinic in Arizona), Oluseyi Abidoye(Mayo Clinic), Mitesh J. Borad(Jacksonville College), Amal M. Youssef(Mayo Clinic Hospital), Hao Xie(Qingdao University), Harry H. Yoon(Mayo Clinic), Þorvarður R. Hálfdánarson(Mayo Clinic), C. O'Donnell(Mayo Clinic in Florida), Lionel Aurelien Kankeu Fonkoua(Mayo Clinic in Arizona), Daniel H. Ahn(WinnMed), Mojun Zhu(Mayo Clinic Hospital), Nguyen H. Tran(Mayo Clinic in Arizona), Jason S. Starr(Mayo Clinic in Florida), Abdullah Alsulaiman(WinnMed), Tanios S. Bekaii-Saab(WinnMed), Katrina S. Pedersen(Mayo Clinic in Arizona), Zhaohu Jin(Mayo Clinic in Arizona), Angelo Pirozzi(Humanitas University)
Cited by 0
Related Papers
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
|JAMA Oncology|2018|1.8k
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer
|Nature Genetics|2009|724